All News
|
News Release
A National Institutes of Health clinical trial evaluating the safety and effectiveness of hydroxychloroquine for the treatment of adults with coronavirus disease 2019 (COVID-19) has formally concluded that the drug provides no clinical benefit to hospitalized patients. Though found not to cause harm, early findings in June when the trial was...
Showing 10 out of 310 results
|
Media Advisory
WHAT: The National Heart, Lung, and Blood Institute (NHLBI) announces selection of Director of the National Center on Sleep Disorders Research (NCSDR). Congress established the NCSDR in 1993 to coordinate sleep research throughout NIH and other federal agencies. Dr. Brown succeeds Michael Twery, Ph.D., who served as the NCSDR director since 2006...
|
News Release
Using a life support machine to replicate the functions of the heart and lungs significantly improved the survival of people who suffered from out-of-hospital cardiac arrest, according to a new study published today in The Lancet . The treatment program involving the life support machine called extracorporeal membrane oxygenation (ECMO) proved so...
|
News Release
A National Institutes of Health clinical trial evaluating the safety and effectiveness of hydroxychloroquine for the treatment of adults with coronavirus disease 2019 (COVID-19) has formally concluded that the drug provides no clinical benefit to hospitalized patients. Though found not to cause harm, early findings in June when the trial was...
Credit: Courtesy of NIH Medical Arts
|
News Release
Targeting cell’s ‘trash compactor’ could lead to new antiviral strategy to fight COVID-19 Researchers at the National Institutes of Health have discovered a biological pathway that the novel coronavirus appears to use to hijack and exit cells as it spreads through the body. A better understanding of this important pathway may provide vital insight...
|
News Release
Los Institutos Nacionales de Salud (NIH, por sus siglas en inglés) anunciaron hoy una subvención de $12 millones para proyectos de promoción de salud y participación comunitaria en regiones con minorías étnicas y raciales afectadas de manera desproporcionada por la pandemia de COVID-19. Con estos fondos, RTI International, una institución de...
|
News Release
The National Institutes of Health today announced a $12 million award for outreach and engagement efforts in ethnic and racial minority communities disproportionately affected by the COVID-19 pandemic. The award to RTI International, a non-profit research institution, will support teams in 11 states established as part of the NIH Community...
|
News Release
The National Institutes of Health has launched two of three adaptive Phase 3 clinical trials evaluating the safety and effectiveness of varying types of blood thinners to treat adults diagnosed with COVID-19. Part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative, these trials will be conducted at more than 100...
|
News Release
The trend could threaten decades of public health work against heart disease After nearly 15 years on an upward trend, awareness among Americans about high blood pressure and how to control and treat it is now on the decline, according to a new study. Even with the help of blood pressure medications, some groups, including older adults, are less...
|
Media Advisory
Study shows treatment does no harm, but provides no benefit What A clinical trial to evaluate the safety and effectiveness of hydroxychloroquine for the treatment of adults hospitalized with coronavirus disease 2019 (COVID-19) has been stopped by the National Institutes of Health. A data and safety monitoring board (DSMB) met late Friday and...
|
News Release
Smoking cessation could be a path to fewer strokes, researchers say African Americans who smoke are nearly 2.5 times more likely to have a stroke than those who never smoked, while former smokers show a similarly lower risk as never smokers, according to a new study funded by the National Institutes of Health. The findings from the Jackson Heart...